Clinical Trial Update: Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial of alisporivir combined with pegylated interferon and ribavirin in protease inhibitor-treatment-failure patients with chronic Hepatitis C was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Alisporivir (alisporivir)
• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Debiopharm International SA | Conditions: Hepatitis C | Phase 3 | Status: TERMINATED | Results posted: 2016-06-27